Concurrent Nivolumab and External Beam Radiation Therapy for Patients With Advanced HCC

Condition:   Advanced Hepatocellular Carcinoma Intervention:   Drug: Nivolumab Sponsors:   National Cancer Center, Korea;   Samsung Medical Center Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials